Future in vitro studies should clarify if BRAF/TERT mutant melanoma cell lines, after exposure to MAPKi and to stimuli activating the TNFR superfamily, show different TERT expression and telomerase activity, as well as different telomere length based on TERTprom mutation type. This evidence concerns the gene TERT and melanoma.